FDA authorizes new diagnostic test for H1N1 influenza

Article

FDA has authorized for use a new test for the diagnosis of H1N1 influenza virus infections. This test was developed by the CDC.

FDA has authorized for use a new test for the diagnosis of H1N1 influenza virus infections. This test was developed by the Centers for Disease Control and Prevention (CDC).

This new test replaces the previous real-time polymerase chain reaction (PCR) diagnostic test that was granted emergency-use authorization by FDA in April 2009. The newly approved PCR panel has been optimized by using all of the available 2009 H1N1 genetic information that CDC received during the outbreak. The test has sensitivity and specificity greater than 96% for upper respiratory specimens.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Related Content
© 2025 MJH Life Sciences

All rights reserved.